Today on Commentary
-
by Hank Cardello - September 3, 2010 4:15pm PDT
Among Glenn Beck's favorite rants is that there is too much interference in what Americans eat. Stuffing ourselves is a God-given right. So are we witnessing the rise of the Pro-Obesity Party?
-
by Erik Sherman - September 3, 2010 3:57pm PDT
HP may have snatched storage vendor 3PAR from Dell, but only at the cost of spending way too much for far too little.
-
by Erik Sherman - September 3, 2010 3:23pm PDT
Apple failed to nail down a deal with Facebook to integrated its new Ping service with the world's largest social network. Don't expect things to change unless Apple backs down on what it wants.
-
by Jim Edwards - September 3, 2010 2:40pm PDT
Is Google (GOOG) CEO Eric Schmidt a child abuser? Of course not, but this satirical cartoon from privacy group Consumer Watchdog hints that he is, in the sense that the search giant offers free...
-
by Erik Sherman - September 3, 2010 2:33pm PDT
Apple is pushing to expand and, as much as possible, control media sales. Sure, Steve Jobs is thinking of himself and his company, but maybe his approach is right.
-
by Alain Sherter - September 3, 2010 2:26pm PDT
Scarily enough, financial regulators hold the key to fixing our financial system. Here's why that's not such a bad thing.
-
by Kirsten Korosec - September 3, 2010 12:34pm PDT
Another explosion in the Gulf - this time a production platform owned by Mariner Energy - raises the question of whether offshore drilling can ever be accident-free.
-
by Brett Snyder - September 3, 2010 11:47am PDT
Southwest pilots are cautioning that the lack of growth at Southwest means they aren't quite sure how they feel about the idea of a new, larger airplane. Will they block an order?
-
by Carol Tice - September 3, 2010 11:45am PDT
As soon as rumors circulated that 3G Capital was looking to buy Burger King, the deal was done. Now the tricky work of improving the chain under new owners begins.
-
by Jim Edwards - September 3, 2010 11:43am PDT
A U.K. vaccine compensation panel's award of £90,000 to the family of a child who became disabled after receiving the measles-mumps-rubella vaccine is being wrongly interpreted as evidence that...
-
by Lydia Dishman - September 3, 2010 11:34am PDT
Luxury shoe and accessories brand Jimmy Choo is rumored to be up for grabs. Read why the company should avoid going public.
-
by Jim Motavalli - September 3, 2010 9:38am PDT
A consensus is emerging that electric cars and plug-in hybrids will need some kind of warning system for pedestrians and blind people, but it's still unclear if such systems will be standard...
-
by Jim Edwards - September 3, 2010 9:18am PDT
If the global economy tips into a double-dip recession it may be all Europe's fault, if the major ad agency holding companies are to be believed.
-
by Damon Brown - September 3, 2010 9:16am PDT
During the Apple music keynote hubbub, rival Sony (SNE) quietly announced Qriocity, a cloud-based subscription music service that will cross all Sony platforms. Atrocious name aside, Qriocity...
-
by Carter Dougherty - September 3, 2010 9:12am PDT
Today we learned that employment is still stagnant. And that the Obama administration is considering a payroll tax holiday. Our reaction should be: it's worth a try.
The Washington Post tells us...
-
by Ben Popper - September 3, 2010 9:06am PDT
Apple and Facebook are fighting over integration on iTunes new social service, Ping. But with so much at stake for both companies, expect them to make up soon.
-
by Jim Edwards - September 3, 2010 8:53am PDT
Did you know that sausages were banned in Byzantium in the 800s? You do now, thanks to one of the front groups Allergan funded to illegally promote Botox.
-
by Brett Snyder - September 2, 2010 5:41pm PDT
The next layer of appointments for the post-merger United has been released, and there are few surprises. There are, however, a couple of positions that go against the grain.
-
by Erik Sherman - September 2, 2010 3:54pm PDT
Twitter needs to make money, and monitoring who clicks on which may offer hope. But it's tactic fraught with privacy land mines for the company.
-
by Jim Edwards - September 2, 2010 3:30pm PDT
Pfizer and Merck are so hobbled by the FDA's lack of guidance on digital marketing that they're reduced to sending spam emails for cholesterol drugs.
About Commentary
Cutting-edge analysis of the day's biggest business stories, from hot companies to the names and faces of the executives who manage them.
Today on MoneyWatch
DVDs & more: Within these categories, you are likely to find better deals (or better products) elsewhere.
More on Moneywatch
Commentary Bloggers
-
Food Fight
-
Wired In
-
The Tagline
-
Financial Folly
-
Carbon Based
-
Headwinds
Commentary Bloggers
-
10-Q Detective
-
Behind the Wheel
-
Capital View
-
Carbon Based
-
Critical Condition
-
Digital Daily
-
Financial Folly
-
Food Fight
-
Gadget Watch
-
Headwinds
-
Last Store Standing
-
Media Creature
-
On the News
-
On the News
-
Placebo Effect
-
Plugged In
-
Retail Reality Check
-
Second Guessing
-
Style Inc.
-
The Tagline
-
Upwardly Mobile
-
Wired In
Breaking News by Industry